HE homepage

obesity semaglutide tirzepatide GLP-1 drugs weight loss

The FDA is now requiring labeling updates for all GLP-1 medications due to a risk of NAION, a rare eye condition that can result in sudden, permanent vision loss.

The decision means Island Peer Review Organization and Network Medical Review will no longer be able to participate in the Independent Dispute Resolution process, which makes rulings on reimbursement conflicts between healthcare payers and providers.

ai artificial intelligence in healthcare

The scheme, which has resulted in two guilty pleas to date, allegedly involved the promise of “free cellphones” as a pretense to get Medicare insurance information from patients, which was then used to bill government programs for unnecessary HIV drugs.

The AI is backed by an LLM and includes an interface allowing for both voice and text chat. It’s available now to anyone who uses the Mayo Clinic Platform, the nonprofit health system’s tech innovation hub.

commercial health insurance

The decision means a moratorium the U.S. Department of Health and Human Services placed on new enrollments for brokers and firms has been lifted. The National Association of Benefits and Insurance Professionals said it will begin training professionals immediately to operate on the federal exchange, and open enrollment is already underway.

Congress in Washington, D.C., is working on legislation to possibly expand Medicare coverage payments for phjysicians.

The 2027 Medicare Physician Fee Schedule includes conversion factors lower than what CMS originally proposed. In addition, a controversial policy many cardiologists are required to participate in is still set to go live on Jan. 1.